Prolonged Reduction of Leukocyte Membrane-Associated Dectin-1 Levels following β-Glucan Administration

Dectin-1 is the primary pattern recognition receptor for fungal glucans. Dectin-1 mediates the internalization and biological response to glucans. We examined the effect of i.v. or i.p. glucan phosphate (GP) administration on Dectin-1 membrane expression in murine peripheral blood leukocytes, splenocytes, bone marrow, and peritoneal cells from 3 h to 10 days after injection. Circulating leukocytes were also examined for uptake and internalization of glucans from the blood. Fluorescent-labeled GP was taken up from the systemic circulation by circulating peripheral leukocytes, splenocytes, and peritoneal cells. Following internalization, glucan colocalized with Dectin-1 in an intracellular vesicle. A single parenteral injection of GP resulted in a significant reduction (∼33-85%) in peripheral leukocyte membrane-associated Dectin-1 positivity that lasted for up to 7 days. The loss of leukocyte membrane-associated Dectin-1 after GP administration was primarily due to decreased levels of Dectin-1 on neutrophil and monocyte membranes with no significant changes in the percentage of neutrophils or monocytes circulating in the blood. Administration of control carbohydrate polymers, i.e., mannan or pullulan, which are not ligands for Dectin-1, did not decrease Dectin-1 leukocyte positivity, indicating that the effect on Dectin-1 is specific to glucans. In fact, mannan administration increased leukocyte Dectin-1 positivity, thus demonstrating a differential effect on leukocyte Dectin-1, compared with GP. We conclude that systemic administration of GP has a specific and prolonged effect on loss of leukocyte membrane Dectin-1 positivity. These data may have important implications for developing dosing regimens for immunomodulatory carbohydrates.

[1]  Andrew H. Limper,et al.  Macrophage Internalization of Fungal β-Glucans Is Not Necessary for Initiation of Related Inflammatory Responses , 2005, Infection and Immunity.

[2]  J. Kalbfleisch,et al.  Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3]  G. Şener,et al.  Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. , 2005, International immunopharmacology.

[4]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[5]  S. Gordon,et al.  Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. , 2004, Blood.

[6]  David L. Williams,et al.  Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats. , 2004, International immunopharmacology.

[7]  Jun Yan,et al.  Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models1 , 2004, The Journal of Immunology.

[8]  David L. Williams,et al.  Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection. , 2004, Cardiovascular research.

[9]  J. Kalbfleisch,et al.  Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis 1 , 2004, The Journal of Immunology.

[10]  S. Gordon,et al.  Fungal β-Glucans and Mammalian Immunity , 2003 .

[11]  Shizuo Akira,et al.  Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.

[12]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[13]  A. Casadevall,et al.  Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils , 2003, European journal of immunology.

[14]  S. Gordon,et al.  The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages1 , 2002, The Journal of Immunology.

[15]  A. Vickers,et al.  Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies , 2002, Cancer Immunology, Immunotherapy.

[16]  Siamon Gordon,et al.  Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.

[17]  J. Kalbfleisch,et al.  Human monocyte scavenger receptors are pattern recognition receptors for (1→3)‐β‐D‐glucans , 2002, Journal of leukocyte biology.

[18]  J. Kalbfleisch,et al.  Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor kappaB activation and interleukin 8 production. Winner of the Best Paper Award from the Gold Medal Forum. , 2002, The American surgeon.

[19]  J. Kalbfleisch,et al.  Human Vascular Endothelial Cells Express Pattern Recognition Receptors for Fungal Glucans Which Stimulates Nuclear Factor κB Activation and Interleukin 8 Production , 2002, The American Surgeon.

[20]  David L. Williams,et al.  Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor‐1 dependent mechanism , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[21]  A. Forsgren,et al.  The importance of a β-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells , 2001 .

[22]  Panagiotis Kougias,et al.  Normal Human Fibroblasts Express Pattern Recognition Receptors for Fungal (1→3)-β-d-Glucans , 2001, Infection and Immunity.

[23]  R. Ritter,et al.  Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning* , 2000, The Journal of Biological Chemistry.

[24]  J. Kalbfleisch,et al.  The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line. , 2000, Glycobiology.

[25]  J. Kalbfleisch,et al.  Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D -glucan increases long-term survival in polymicrobial sepsis , 1999 .

[26]  David L. Williams Overview of (1→3)-β-D-glucan immunobiology , 1997, Mediators of inflammation.

[27]  Edward J. Walsh Chemistry and Biology , 1996 .

[28]  David L. Williams,et al.  Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. , 1996, Journal of immunology.

[29]  E. Jones,et al.  Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. , 1995, Journal of chromatography. B, Biomedical applications.

[30]  E. Jones,et al.  NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Carbohydrate research.

[31]  E. Jones,et al.  A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1991, Carbohydrate research.

[32]  M. Tsuchiya,et al.  A novel endotoxin-specific assay by turbidimetry with Limulus amoebocyte lysate containing beta-glucan. , 1991, Journal of biochemical and biophysical methods.

[33]  I. Browder,et al.  Chemoimmunotherapy of experimental hepatic metastases , 1987, Hepatology.

[34]  E. Lotzová,et al.  Modulation of murine hemopoiesis by glucan. , 1980, Experimental hematology.

[35]  C. J. Chamberlain The Cell Wall , 1907, Botanical Gazette.

[36]  A. Forsgren,et al.  The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. , 2001, The Journal of infectious diseases.

[37]  G. D. Brown,et al.  Immune recognition. A new receptor for beta-glucans. , 2001, Nature.

[38]  T. E. Edwards,et al.  6. Polysaccharides of baker's yeast. Part IV. Mannan , 1961 .